South Korea at a glance
- Population
- 51.7 million 2025
- Life expectancy at birth
- 83.6 years, 2024
- People aged 65 and over
- 20.3 % of people, 2025
- Health spending per person
- 3,137 US$ per person, 2024
- Doctors
- 2.61 per 1,000 people, 2022
Updated
Reviewed by Chandani Patel
South Korea Genetic Testing Market Industry Trends and Forecast to 2034: Segmented by (Type, Technology, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$800.2 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $382.0 Mn | — | — |
| 2025 (base) | $429.4 Mn | +$47.4 Mn | — |
| 2026 (forecast) | $482.7 Mn | +$53.2 Mn | +12.4% |
| 2027 (forecast) | $542.5 Mn | +$59.9 Mn | +26.3% |
| 2028 (forecast) | $609.8 Mn | +$67.3 Mn | +42% |
| 2029 (forecast) | $685.4 Mn | +$75.6 Mn | +59.6% |
| 2030 (forecast) | $770.4 Mn | +$85.0 Mn | +79.4% |
| 2031 (forecast) | $865.9 Mn | +$95.5 Mn | +101.6% |
| 2032 (forecast) | $973.3 Mn | +$107.4 Mn | +126.7% |
| 2033 (forecast) | $1.09 Bn | +$120.7 Mn | +154.8% |
| 2034 (forecast) | $1.23 Bn | +$135.7 Mn | +186.3% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $429.4 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $1.23 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 12.4% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Type, technology and end user (see all) |
| Key players | Myriad Genetics, Inc., Illumina, Inc., Natera, Invitae, Quest Diagnostics and 1 more (see all) |
| Regulator in South Korea | MFDSSource: Ministry of Food and Drug Safety. Checked 19 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Genetic testing reads a person's DNA to find inherited conditions, cancer risk, drug response and family links.
Key segments of the genetic testing market include type (Predictive Testing, Carrier Testing and Diagnostic Testing) and technology (PCR, Sequencing and Microarrays).
Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the genetic testing market.
Automation, smaller and cheaper instruments and growth in cancer and genetic testing give the genetic testing market room to grow.
Costly instruments, a shortage of skilled lab staff and uneven payment for new tests hold back the genetic testing market.
The genetic testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices are classed by risk and need notification, certification or approval under the Ministry of Food and Drug Safety (MFDS).[1] Everyone is covered by National Health Insurance; the Health Insurance Review and Assessment Service (HIRA) reviews claims and what is covered.[2]
[1] Ministry of Food and Drug Safety. Checked 19 Nov 2026.
[2] Health Insurance Review and Assessment Service (HIRA). Checked 19 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how genetic testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in South Korea.
What doctors and scientists are doing in Genetic Testing right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.
From our blog
South Korea · 3 shared keywords
South Korea
South Korea
South Korea
South Korea
South Korea
Pharmaceuticals · Global
Digital Health · Global
Healthcare Services · Global
Healthcare Services · Global
Digital Health · Global
Healthcare Services · Global